Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
glycerol-3-phosphate transporter
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| W355Ter | - | nonsense mutation, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene Catalog | Confirmed |
| W137R | - | single resistance variant, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene CatalogReslit |
| A100V | - | single resistance variant, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene CatalogReslit | Confirmed |
| F3I | - | single resistance variant, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene CatalogReslit | Confirmed |
| V213I | - | single resistance variant, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene Catalog | Confirmed |
| L27F | - | single resistance variant, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene CatalogReslit | Confirmed |
| G352D | - | single resistance variant, glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene Catalog | Confirmed |
| T211P | - | glycerol-3-phosphate transporter GlpT | Pseudomonas aeruginosa | FosfomycinFOSFOMYCIN | Reference Gene CatalogReslit | Confirmed |
| D274V | - | deficiency | Klebsiella pneumoniae | Fosfomycin | Reslit | Candidate |
| E299D | - | deficiency | Klebsiella pneumoniae | Fosfomycin | Reslit | Candidate |
| E374A | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| L297F | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| Q444E | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| E443Q | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| W413X | - | inactivating | Pseudomonas aeruginosa | Aminoglycoside | Reslit | Candidate |
| E448K | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| Q437C | - | - | E. coli | Fosfomycin | Reslit | Candidate |
| F176S | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| V149M | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| I4V | - | - | E. coli | Fosfomycin | Reslit | Candidate |
| R50C | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| G84D | - | - | E. coli, Escherichia coli | Fosfomycin | Reslit | Supported |
| A156V | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| P173S | - | - | E. coli | Fosfomycin | Reslit | Candidate |
| R209H | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| A12V | - | - | E. coli | Fosfomycin | Reslit | Candidate |
| G142C | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| T144P | - | - | E. coli | Fosfomycin | Reslit | Candidate |
| L174V | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| G358S | - | - | - | Fosfomycin | Reslit | Candidate |
| D88E | - | - | - | Fosfomycin | Reslit | Candidate |
| E41K | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| P7N | - | - | Escherichia coli, Citrobacter freundii | Fosfomycin | Reslit | Candidate |
| A8Q | - | - | Escherichia coli, Citrobacter freundii | Fosfomycin | Reslit | Candidate |
| K6L | - | - | Citrobacter freundii, Escherichia coli | Fosfomycin | Reslit | Candidate |
| A16T | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| W335* | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| E195K | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| F133C | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| M52L | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| A197V | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| L373R | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| P212L | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| G135W | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| G168E | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| A434V | - | glycerol-3-phosphate transporter GlpT | Staphylococcus aureus | FOSFOMYCIN | Reference Gene Catalog | Established |
| - | - | - | Fosfomycin | Reslit | Candidate |
| G141del | - | - | Fosfomycin | Reslit | Candidate |
| - | - | - | Fosfomycin | Reslit | Candidate |
| P134* | - | Klebsiella pneumoniae | Fosfomycin | Reslit | Candidate |
| - | - | - | Fosfomycin | Reslit | Candidate |
| - | - | - | Fosfomycin | Reslit | Candidate |
| - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| glpT | Reslit | 22 | Fosfomycin, Fosmidomycin +23 | Pseudomonas aeruginosa +8 | Spain, India, Greece, Shanghai, Sichuan, China, China|USA|Canada|Germany|Brazil|France|Japan|Ecuador|India|Australia|Taiwan|Hungary|Caribbean|South Africa, North India, Iraq, Poland, Europe | 2010, 2015, 2017, 2019, 2020, 2021, 2022, 2023, 2024, 2025 | PRJEB21341|ERS1792085|ERS1792128 | - |
| glpt | Reslit | 1 | Fosfomycin | Pseudomonas aeruginosa | China | 2019 | CP024630|CP024631 | - |
| GlpT | Reslit | 1 | Fosfomycin | Staphylococcus aureus DC.RB_015 | Yunnan, China | 2022 | BioProject PRJNA762640|BioSample SAMN21399875|Nucleotide CP083434|Nucleotide CP083435 | - |
| glp T | Reslit | 1 | Fosfomycin | Escherichia coli +2 | Edo state, Nigeria | 2022 | JAIKTX000000000|JAIKUW000000000|JAIKTX010000000|JAIKUW010000000 | - |
| glpT_E448K | Reslit | 3 | Tetracycline, Fosfomycin | Escherichia coli +4 | Pakistan, Europe|Brazil, Peru | 2024, 2025 | CP1557270|CP155728 | - |
Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.
Identification of a second two-component signal transduction system that controls fosfomycin tolerance and glycerol-3-phosphate uptake.
The study identifies the Tor system as a second two-component signal transduction system that controls fosfomycin tolerance and glycerol-3-phosphate uptake in EHEC. Activation of the Tor pathway represses glpT expression, leading to reduced fosfomycin uptake and increased tolerance.
Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.
The study shows that elevated expression of glpT and uhpT in anaerobic conditions increases fosfomycin susceptibility in E. coli by enhancing drug uptake.
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
The study identified various AMR genes and mutations in extensively drug-resistant Pseudomonas aeruginosa isolates from Spain, including beta-lactamases, aminoglycoside-modifying enzymes, and mutations in genes such as ampC, oprD, gyrA, parC, mexZ, and glpT, which contribute to resistance against multiple antibiotics.
Epidemiology and molecular characterization of the antimicrobial resistance of Pseudomonas aeruginosa in Chinese mink infected by hemorrhagic pneumonia.
The study identified fosA and glpt genes associated with fosfomycin resistance in Pseudomonas aeruginosa isolates from Chinese mink, as well as mutations in gyrA and parC contributing to fluoroquinolone resistance.
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa.
The study identifies multiple AMR genes and mutations in Pseudomonas aeruginosa CL232, including bla PDC-34, bla OXA-488, and various efflux pumps, which contribute to resistance against ceftazidime, fosfomycin, and other antibiotics. It also shows that the combination of ceftazidime-avibactam and fosfomycin is effective against multidrug-resistant P. aeruginosa.
Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples.
The study identifies fosA3 as a novel plasmid-mediated fosfomycin resistance gene in E. coli isolates in Spain. Fosfomycin resistance is primarily due to defects in the UhpT transporter system, while nitrofurantoin resistance involves mutations in nfsA, nfsB, and ribE genes.
Genetic Determinants of Antibiotic Resistance in Francisella.
The paper reviews the genetic determinants of antibiotic resistance in Francisella, focusing on intrinsic resistance mechanisms and the roles of specific genes such as beta-lactamases, efflux pumps, and LPS modification genes.
Whole genome sequence analysis of multi drug resistant community associated methicillin resistant Staphylococcus aureus from food fish: detection of clonal lineage ST 28 and its antimicrobial resistance and virulence genes.
The study identifies several antimicrobial resistance genes in a multi-drug resistant community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain isolated from fish, including mepR, mgrA, arlR, lmrS, fosB, norA, glpT, and murA, which confer resistance to various antibiotics such as glycylcycline, tetracycline, fluoroquinolone, cephalosporin, penam, macrolide, aminoglycoside, oxazolidinone, diaminopyrimidine, phenicol, fosfomycin, and acridine dye.
Antibiotic Resistance of Staphylococci from Bulk-Tank Milk of Sheep Flocks: Prevalence, Patterns, Association with Biofilm Formation, Effects on Milk Quality, and Risk Factors.
The study identified antibiotic resistance in staphylococcal isolates from bulk-tank milk of sheep flocks in Greece, with particular emphasis on resistance to penicillin, ampicillin, clindamycin, fosfomycin, tetracycline, oxacillin, and erythromycin. It also noted an association between fosfomycin resistance and biofilm formation.
Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales.
The study identifies several genes and mechanisms contributing to fosfomycin resistance in Pseudomonas aeruginosa, including peptidoglycan recycling enzymes (mupP, amgK, murU), the glpT transporter, and the chromosomal fosA gene.
Prevalence and antimicrobial resistance profiling of Staphylococcus aureus isolated from traditional cheese in Yunnan, China.
The study identified 18 antimicrobial resistance genes in Staphylococcus aureus strain DC.RB_015, including mecA, blaZ, mepA, tet(K), tet(38), arlR, arlS, norA, mgrA, LmrS, APH(3′)-IIIa, aad(6), ErmB, SAT-4, mecR1, GlpT, murA, and bacA, which confer resistance to various antibiotics such as methicillin, beta-lactam, tetracycline, fluoroquinolone, macrolide, aminoglycoside, nucleoside, fosfomycin, and bacitracin.
Genetic Characterization of Antibiotic Resistant Enterobacteriaceae Isolates From Bovine Animals and the Environment in Nigeria.
The study characterizes antibiotic resistance genes in Enterobacteriaceae isolates from bovine animals and the environment in Nigeria, identifying several beta-lactamase, aminoglycoside modifying enzymes, qnr, sulfonamide, tetracycline, and trimethoprim resistance genes, highlighting the presence of multidrug-resistant strains.
Mechanisms of high-level fosfomycin resistance in Staphylococcus aureus epidemic lineage ST5.
High-level fosfomycin resistance in S. aureus ST5 lineage is mainly due to mutations in glpT and uhpT, whereas ST239 resistance is mainly due to mutations in hptA.
Phenotypic and genotypic characterization of antimicrobial resistance profiles in Salmonella isolated from waterfowl in 2002-2005 and 2018-2020 in Sichuan, China.
The study identified multiple AMR genes and mutations in Salmonella isolates from waterfowl in Sichuan, China, including beta-lactamases, aminoglycoside-modifying enzymes, tetracycline efflux pumps, and quinolone resistance genes. Mutations in gyrA and gyrB were associated with nalidixic acid resistance.
Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus.
The paper discusses the molecular mechanisms of resistance to non-beta-lactam antibiotics in Staphylococcus aureus, highlighting the roles of various genes and mutations in conferring resistance to macrolides, lincosamides, aminoglycosides, glycopeptides, oxazolidinones, lipopeptides, fluoroquinolones, and other antibiotics.
Pervasive Selection for Clinically Relevant Resistance and Media Adaptive Mutations at Very Low Antibiotic Concentrations.
The study identifies clinically relevant resistance mutations in E. coli under subMIC antibiotic concentrations, showing that mutations in glpT, uhpT, uhpC, uhpA, nfsA, nfsB, gyrA, gyrB, and envZ confer resistance to fosfomycin, nitrofurantoin, ciprofloxacin, and tetracycline.
Fosfomycin Resistance in Bacteria Isolated from Companion Animals (Dogs and Cats).
The study identifies fosA, fosA3, fosB, murA, and glpT as genes conferring fosfomycin resistance in bacteria isolated from companion animals. These genes were experimentally validated in various bacterial species, highlighting the spread of fosfomycin resistance among multidrug-resistant bacteria in pets.
Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment.
This review discusses the molecular basis of challenges to effective treatment of UPEC-associated urinary tract infections, focusing on virulence factors and antibiotic resistance mechanisms.
An insight into genes responsible for fosfomycin resistance among uropathogens of asymptomatic bacteriuria during pregnancy: A North Indian study.
The study identified murA, glpT, and fosA genes as contributors to fosfomycin resistance in uropathogens causing asymptomatic bacteriuria during pregnancy.
Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.
The study identified the genes murA, glpT, cyaA, fosA3, and fosA4 as associated with fosfomycin resistance in uropathogenic Escherichia coli (UPEC). These genes were detected in both chromosomal and plasmid contexts, highlighting their role in resistance mechanisms.
Genomic Analysis of Cronobacter condimenti s37: Identification of Resistance and Virulence Genes and Comparison with Other Cronobacter and Closely Related Species.
The study identified 17 antimicrobial resistance genes in Cronobacter condimenti s37, including genes involved in resistance to multiple antibiotic classes such as beta-lactams, tetracyclines, macrolides, phenicols, quinolones, aminoglycosides, glycopeptides, peptide antibiotics, rifamycins, nitroimidazoles, phosphonic acid derivatives, diaminopyrimidine derivatives, and elphamycins.
Analyzing Antibiotic Resistance in Bacteria from Wastewater in Pakistan Using Whole-Genome Sequencing.
The study identifies several AMR genes and mutations in wastewater isolates from Pakistan, highlighting the presence of carbapenemases like blaNDM-5 and blaOXA-1, as well as quinolone resistance determinants such as gyrA and parC mutations. These findings emphasize the role of wastewater as a reservoir for clinically relevant AMR genes.
Detection of Possible Resistance Mechanisms in Uropathogenic Escherichia coli Strains Isolated from Kidney Transplant Recipients Based on Whole Genome Sequencing.
The study identifies mutations in the gyrA gene and the presence of the qnrS1 gene as key contributors to quinolone resistance in uropathogenic E. coli strains. Additionally, mutations in glpT, cyaA, and uhpT genes are associated with fosfomycin resistance.
Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus.
The study found that daptomycin and fosfomycin combination displayed synergistic antibacterial activity against MRSA and prevented the emergence of drug-resistant mutants. Specific mutations in mprF, cls2, uhpT, and murA genes were identified in single-drug resistant mutants, but no mutations were detected in the combination group.
Genomic Analysis of Antibiotic Resistance and Virulence Profiles in Escherichia coli Linked to Sternal Bursitis in Chickens: A One Health Perspective.
The study identified multiple AMR genes and mutations in E. coli isolates from sternal bursitis in chickens, including beta-lactamases (blaTEM-1B, blaTEM-1A, blaTEM-1C, blaCTX-M-1, blaOXA-10), chloramphenicol resistance genes (catA1, cmlA1, floR), aminoglycoside resistance genes (aph(6)-Id, aph(3")-Ib, aadA1, aadA2b, aadA5, aadA9, aadA13, sat2), quinolone resistance gene (qnrS1), tetracycline resistance gene (tetA), sulfonamide resistance genes (sul1, sul2, sul3), and efflux pump genes (acrF, mdtM, ermE, qacE, qacL, terD, terW, terZ). Mutations in gyrA (p.S83L) and parC (p.E84G, p.S80I) were associated with quinolone resistance, and a mutation in glpT (E448K) was linked to fosfomycin resistance.
Genomic Characterization of Escherichia coli Isolates from Alpaca Crias (Vicugna pacos) in the Peruvian Highlands: Insights into Functional Diversity and Pathogenicity.
The study identified several antimicrobial resistance genes and mutations in E. coli isolates from alpaca crias, including blaEC-15 for beta-lactam resistance, glpT_E448K for fosfomycin resistance, and pmrB for colistin resistance.
Multidrug-resistant Pseudomonas aeruginosa: Pathogenesis, resistance mechanisms, and novel therapeutic strategies.
The paper discusses the multidrug resistance mechanisms of Pseudomonas aeruginosa, including beta-lactamases, aminoglycoside modifying enzymes, efflux pumps, and mutations in porin genes. It highlights the role of these mechanisms in antibiotic resistance and the challenges they pose in treating infections.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research